A Study of ERAS-601 in People With Chordoma
Clinical trial NCT06957327 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06957327
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-25
- Primary completion
- 2027-04-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.